{"id":35904,"date":"2021-12-25T12:00:21","date_gmt":"2021-12-25T12:00:21","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=35904"},"modified":"2024-07-15T09:22:39","modified_gmt":"2024-07-15T09:22:39","slug":"effective-epi-on-cxl","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/effective-epi-on-cxl\/","title":{"rendered":"CXL epi-on eficaz - TouchOphthalmology entrevista o Prof. Hafezi"},"content":{"rendered":"<p><a href=\"https:\/\/www.touchophthalmology.com\/cornea\/conference-hub\/farhad-hafezi-escrs-2021-development-of-an-effective-epithelium-on-procedure\/\">TouchOphthalmology entrevistou o Prof. Farhad Hafezi<\/a> sobre a raz\u00e3o pela qual foi preciso esperar at\u00e9 agora para ter uma solu\u00e7\u00e3o CXL epi-on eficaz.<\/p>\n<p><iframe src=\"https:\/\/player.vimeo.com\/video\/649877925?h=a02ece13c5&amp;dnt=1&amp;app_id=122963\" width=\"800\" height=\"450\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<p>Transcri\u00e7\u00e3o:<\/p>\n<p>Ol\u00e1, este \u00e9 o <a href=\"https:\/\/www.elza-institute.com\/pt\/sobre\/farhad-hafezi\/\">Farhad Hafezi<\/a> do Instituto ELZA em Zurique, Su\u00ed\u00e7a. Sou cirurgi\u00e3o refrativo da c\u00f3rnea e bi\u00f3logo celular. A principal raz\u00e3o pela qual demorou tanto tempo a obter um CXL epi-on eficaz prende-se com o facto de, no in\u00edcio de 2005\/6, ainda n\u00e3o termos identificado todos os factores necess\u00e1rios para que o cross-linking ocorra com \u00eaxito.<\/p>\n<p>Por isso, atualmente sabemos que, para al\u00e9m da luz e da riboflavina, <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24349884\/\">tamb\u00e9m precisamos de oxig\u00e9nio<\/a>E isto s\u00f3 foi descoberto em 2014 pelo meu grupo em Genebra. Assim, uma vez que sab\u00edamos que o oxig\u00e9nio \u00e9 um fator limitante, sab\u00edamos que o epi-on tinha duas grandes limita\u00e7\u00f5es a ultrapassar: precisamos de riboflavina suficiente na c\u00f3rnea e precisamos de oxig\u00e9nio suficiente em todos os momentos. Pessoalmente, sempre me esforcei por conseguir o procedimento mais simples poss\u00edvel.<\/p>\n<p>Portanto, em termos de transporte de riboflavina para a c\u00f3rnea, j\u00e1 t\u00ednhamos uma solu\u00e7\u00e3o utilizando a iontoforese h\u00e1 alguns anos, mas isto significa simplesmente mais um dispositivo. N\u00e3o \u00e9 f\u00e1cil colocar este pequeno anel de suc\u00e7\u00e3o na c\u00f3rnea. Ele cai, a riboflavina vai para todo o lado. S\u00f3 complica as coisas. Por isso, pessoalmente, est\u00e1vamos a pensar em como utilizar os potenciadores de penetra\u00e7\u00e3o, a concentra\u00e7\u00e3o e composi\u00e7\u00e3o corretas para omitir esta tecnologia adicional e utilizar apenas potenciadores de penetra\u00e7\u00e3o e riboflavina.<\/p>\n<p>Este \u00e9 o primeiro passo. O outro passo para desenvolver uma solu\u00e7\u00e3o CXL epi-on eficaz foi como ultrapassar a limita\u00e7\u00e3o do transporte de oxig\u00e9nio para a c\u00f3rnea se o epit\u00e9lio estiver intacto? E uma ideia, que fundament\u00e1mos nas nossas publica\u00e7\u00f5es cient\u00edficas, seria n\u00e3o utilizar os 21% que temos \u00e0 nossa volta no ar circundante, mas ter 100% de oxig\u00e9nio \u00e0 volta do cone. Foi por isso que, h\u00e1 dois ou tr\u00eas anos, surgiu o conceito destes \u00f3culos de oxig\u00e9nio. Faz todo o sentido, mas, mais uma vez, \u00e9 outra tecnologia. Por isso, a minha miss\u00e3o era encontrar a combina\u00e7\u00e3o perfeita de factores que nos permitisse fazer epi-on sem iontoforese e sem oxig\u00e9nio adicional.<\/p>\n<p>Um grande agradecimento a Cosima Mazzotta, de It\u00e1lia, porque publicou h\u00e1 alguns meses o t\u00f3pico<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32396639\/\">eano de acompanhamento do seu pr\u00f3prio procedimento<\/a>O m\u00e9dico n\u00e3o precisou de oxig\u00e9nio adicional porque utilizou uma combina\u00e7\u00e3o muito inteligente de alta frequ\u00eancia, luz pulsada e acelera\u00e7\u00e3o suave.<\/p>\n<p>Mas continuava a precisar de iontoforese. Por isso, no \u00faltimo ano, tenho estado a trabalhar no Instituto Federal Su\u00ed\u00e7o de Tecnologia para perceber como \u00e9 que se pode trazer mais riboflavina para o coronav\u00edrus sem iontoforese. J\u00e1 l\u00e1 cheg\u00e1mos. Portanto, o que temos agora \u00e9 um epi-on funcional com uma elevada taxa de sucesso sem iontoforese, com o oxig\u00e9nio ambiente. E isto \u00e9 o que todos n\u00f3s temos estado \u00e0 procura.<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>A TouchOphthalmology entrevistou o Prof. Farhad Hafezi sobre o motivo pelo qual foi preciso esperar at\u00e9 agora para ter uma solu\u00e7\u00e3o CXL epi-on eficaz.<\/p>","protected":false},"author":4,"featured_media":35988,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[214,1,96],"tags":[209,132,125,130,100,134,135],"class_list":["post-35904","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farhad-hafezi","category-general-news","category-popular-press","tag-basic-research","tag-biomechanics","tag-cornea","tag-cross-linking","tag-cxl","tag-epi-on","tag-transepithelial"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Effective epi-on CXL - TouchOphthalmology interviews Prof. Hafezi -<\/title>\n<meta name=\"description\" content=\"TouchOphthalmology interviewed Prof. Farhad Hafezi on why it&#039;s taken until now to have an effective epi-on CXL solution.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/effective-epi-on-cxl\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Effective epi-on CXL - TouchOphthalmology interviews Prof. Hafezi -\" \/>\n<meta property=\"og:description\" content=\"TouchOphthalmology interviewed Prof. Farhad Hafezi on why it&#039;s taken until now to have an effective epi-on CXL solution.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/effective-epi-on-cxl\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-25T12:00:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-15T09:22:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/12\/Touch-featured-image-interview.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"Effective epi-on CXL &#8211; TouchOphthalmology interviews Prof. Hafezi\",\"datePublished\":\"2021-12-25T12:00:21+00:00\",\"dateModified\":\"2024-07-15T09:22:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/\"},\"wordCount\":473,\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Touch-featured-image-interview.jpg\",\"keywords\":[\"Basic Research\",\"Biomechanics\",\"Cornea\",\"Cross-Linking\",\"CXL\",\"epi-on\",\"Transepithelial\"],\"articleSection\":[\"Farhad Hafezi\",\"News\",\"Popular press\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/\",\"name\":\"Effective epi-on CXL - TouchOphthalmology interviews Prof. Hafezi -\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Touch-featured-image-interview.jpg\",\"datePublished\":\"2021-12-25T12:00:21+00:00\",\"dateModified\":\"2024-07-15T09:22:39+00:00\",\"description\":\"TouchOphthalmology interviewed Prof. Farhad Hafezi on why it's taken until now to have an effective epi-on CXL solution.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Touch-featured-image-interview.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Touch-featured-image-interview.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Effective epi-on CXL \u2013 TouchOphthalmology interviews Prof. Hafezi\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/effective-epi-on-cxl\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/general-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Effective epi-on CXL &#8211; TouchOphthalmology interviews Prof. Hafezi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.elza-institute.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ELZA.Institute\\\/\",\"https:\\\/\\\/x.com\\\/ELZA_Institute\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/pt\\\/author\\\/markhillen\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CXL epi-on eficaz - TouchOphthalmology entrevista o Prof. Hafezi -","description":"A TouchOphthalmology entrevistou o Prof. Farhad Hafezi sobre o motivo pelo qual foi preciso esperar at\u00e9 agora para ter uma solu\u00e7\u00e3o CXL epi-on eficaz.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/effective-epi-on-cxl\/","og_locale":"pt_PT","og_type":"article","og_title":"Effective epi-on CXL - TouchOphthalmology interviews Prof. Hafezi -","og_description":"TouchOphthalmology interviewed Prof. Farhad Hafezi on why it's taken until now to have an effective epi-on CXL solution.","og_url":"https:\/\/www.elza-institute.com\/pt\/effective-epi-on-cxl\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2021-12-25T12:00:21+00:00","article_modified_time":"2024-07-15T09:22:39+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/12\/Touch-featured-image-interview.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"Effective epi-on CXL &#8211; TouchOphthalmology interviews Prof. Hafezi","datePublished":"2021-12-25T12:00:21+00:00","dateModified":"2024-07-15T09:22:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/"},"wordCount":473,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/12\/Touch-featured-image-interview.jpg","keywords":["Basic Research","Biomechanics","Cornea","Cross-Linking","CXL","epi-on","Transepithelial"],"articleSection":["Farhad Hafezi","News","Popular press"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/","url":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/","name":"CXL epi-on eficaz - TouchOphthalmology entrevista o Prof. Hafezi -","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/12\/Touch-featured-image-interview.jpg","datePublished":"2021-12-25T12:00:21+00:00","dateModified":"2024-07-15T09:22:39+00:00","description":"A TouchOphthalmology entrevistou o Prof. Farhad Hafezi sobre o motivo pelo qual foi preciso esperar at\u00e9 agora para ter uma solu\u00e7\u00e3o CXL epi-on eficaz.","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/12\/Touch-featured-image-interview.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2021\/12\/Touch-featured-image-interview.jpg","width":1200,"height":600,"caption":"Effective epi-on CXL \u2013 TouchOphthalmology interviews Prof. Hafezi"},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/effective-epi-on-cxl\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.elza-institute.com\/general-news\/"},{"@type":"ListItem","position":3,"name":"Effective epi-on CXL &#8211; TouchOphthalmology interviews Prof. Hafezi"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/35904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=35904"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/35904\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/35988"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=35904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=35904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=35904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}